Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Dec 5, 2023
Date Accepted: Aug 20, 2024

The final, peer-reviewed published version of this preprint can be found here:

Influenza-Like Illness in Lesotho From July 2020 to July 2021: Population-Based Participatory Surveillance Results

Greenleaf AR, Francis S, Zhou J, Farley SM, Lekhela T, Asiimwe F, Chen Q

Influenza-Like Illness in Lesotho From July 2020 to July 2021: Population-Based Participatory Surveillance Results

JMIR Public Health Surveill 2024;10:e55208

DOI: 10.2196/55208

PMID: 39378443

PMCID: 11479357

Influenza-like illness symptoms as reported by a population-based participatory surveillance system in Lesotho, July 2020- July 2021

  • Abigail R Greenleaf; 
  • Sarah Francis; 
  • Jungang Zhou; 
  • Shannon M Farley; 
  • Tšepang Lekhela; 
  • Fred Asiimwe; 
  • Qixuan Chen

ABSTRACT

Background:

Participatory surveillance – a public population at risk reporting symptoms using technology – can supplement existing surveillance systems. In Lesotho, a landlocked country of 2 million people in Southern Africa, the laboratory and case-based COVID-19 surveillance systems were complemented by a participatory surveillance system called “LeCellPHIA” (Lesotho Cell phone Population-based HIV Impact Assessment Survey).

Objective:

This report describes person, place, and time of ILI in Lesotho from July 15, 2020 to July 15, 2021.

Methods:

LeCellPHIA was built from the 2020 Lesotho Population-Based HIV Impact Assessment (LePHIA2020) survey. LePHIA2020 was a cross-sectional nationally representative household survey that assessed the prevalence of key human immunodeficiency virus (HIV) related health indicators. LeCellPHIA employed interviewers to call participants to enquire weekly about influenza-like illness (ILI) among a nationally representative sample of LePHIA 2020 participants.

Results:

The LeCellPHIA ILI participatory surveillance system captured 122,985 weekly reports of symptomology in Lesotho from July 2020- 2021. Influenza-like illness trends from LeCellPHIA mirror COVID-19 testing data trends; with an epidemic peak in mid- to late- January 2021. Overall, report of any ILI symptoms (fever, dry cough, shortness of breath) were reported at an average weekly rate of 879 per 100,000 at risk (95% Confidence Interval (CI): 782- 988). ILI was highest among men aged 60 and older (1,124 per 100,000; 95% CI 836 - 1512). The overall response rate for the year of data collection was 75%. Weekly data were shared with the National COVID-19 Secretariat and other stakeholders to monitor ILI trends, identify and respond to increases in report of ILI, and inform policies and practices designed to reduce COVID-19 transmission in Lesotho.

Conclusions:

LeCellPHIA, an innovative and cost-effective system, could be replicated in countries where phone ownership is high but internet use is not yet high enough for a web or app-based system.


 Citation

Please cite as:

Greenleaf AR, Francis S, Zhou J, Farley SM, Lekhela T, Asiimwe F, Chen Q

Influenza-Like Illness in Lesotho From July 2020 to July 2021: Population-Based Participatory Surveillance Results

JMIR Public Health Surveill 2024;10:e55208

DOI: 10.2196/55208

PMID: 39378443

PMCID: 11479357

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.